Skip to content
Phenmetrazine
Preludin (phenmetrazine) is a small molecule pharmaceutical. Phenmetrazine was first approved as Preludin on 1982-01-01. It is used to treat obesity in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nutritional and metabolic diseasesD009750
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Phenmetrazine hydrochloride
Tradename
Company
Number
Date
Products
PRELUDINBoehringer IngelheimN-010460 DISCN1982-01-01
1 products
PRELUDINBoehringer IngelheimN-011752 DISCN1982-01-01
2 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
obesityEFO_0001073D009765E66.9
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
7 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dry eye syndromesD015352H04.1211
Allergic conjunctivitisD003233EFO_0007141H10.4411
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Respiratory tract infectionsD012141J06.911
Cold temperatureD00308011
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Fuchs' endothelial dystrophyD005642EFO_0003946H18.5111
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePHENMETRAZINE
INNphenmetrazine
Description
Phenmetrazine is a member of the class of morpholines that is morpholine substituted with a phenyl group at position 2 and a methyl group at position 3. It has a role as a metabolite and a sympathomimetic agent. It is functionally related to a morpholine.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC1NCCOC1c1ccccc1
Identifiers
PDB
CAS-ID134-49-6
RxCUI
ChEMBL IDCHEMBL1201208
ChEBI ID8067
PubChem CID4762
DrugBankDB00830
UNII IDXA501VL3VR (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 613 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
9,789 adverse events reported
View more details